Get notified when RANI files again. Create a free account and we'll email you the moment its next filing is analyzed.

Get filing alerts

Red Flags Detected

  • Material Weakness (new) — Company disclosed a new material weakness in controls over complex transactions as of December 31, 2025, rendering disclosure controls ineffective.
  • Going Concern (removed) — Auditor removed going-concern paragraph after company raised $60M+ and improved liquidity from $27.6M to $49.7M in cash/marketable securities.
  • Auditor Change (new) — Marcum LLP's attest business was acquired by CBIZ CPAs P.C. effective November 1, 2024, resulting in auditor change mid-period.
NASDAQ: RANI Rani Therapeutics Holdings, Inc. 10-K

Rani raises $60M, secures Chugai deal, repays all debt—but discloses control weakness

Filed March 26, 2026 · Period ending December 31, 2025 · Compared to 10-K Mar 31, 2025 · ~2 min read

Key Changes

  • high

    Company raised $60M via October private placement, secured $10M upfront from Chugai collaboration (up to $185M in milestones), and repaid all debt ($7.9M), eliminating going-concern doubt and becoming debt-free.

    MD&A: Liquidity & Capital Resources verify on EDGAR →
  • high

    Initiated Phase 1 trial for RT-114 obesity drug (RaniPill HC platform) in December 2025, advancing first high-capacity device into human testing after preclinical validation.

    Business: Pipeline Development verify on EDGAR →
  • high

    Discontinued RT-102 (osteoporosis) and RT-110 (hypoparathyroidism) programs; cut headcount 34% (105 to 69 employees) as part of strategic refocusing on obesity and partnerships.

    Business: Strategic Prioritization verify on EDGAR →

2 more material changes behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.

Read 3 full reports/month free No card required. Takes 30 seconds.

Want to see a complete report first? Today's free report (PXED 10-Q) is open in full — no account needed.

Partner

Trade RANI commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Was this report useful?
View original filing on SEC.gov View full financials on EDGAR ↗

Source-verified from EDGAR · Narrative written by AI · Jun 4, 2026 · How we verify